Connect with us

News

Know Your Specialist

Published

on

Dr Emily Shava is a medical doctor (MBChB from University of Zimbabwe 2004) with a Master of Science in Clinical Trials (London School of Hygiene and Tropical Medicine 2016.)

She has been involved in clinical research in Botswana through Botswana Harvard AIDS Institute Partnership, since November 2009. Thus she has had the opportunity to work with different stakeholders and communities in the country since then.

Here she tells RACHEL RADITSEBE about the ongoing AMP Study Enrolment is ongoing in the Antibody-Mediated Prevention (AMP) study.

Tell us about that. What is AMP and how exactly does it work? AMP stands for Antibody Mediated Prevention. This is a multicentre study being conducted in different countries by two global networks known as HIV Prevention Trials Network (HPTN) and HIV Vaccine Trials Network (HVTN). The AMP study in Sub-Saharan Africa is enrolling women and is also known as HVTN 703/HPTN081 Study.

Women because in Africa they are among those at highest risk of HIV infection because of their physiology and gender based imbalances. In this study broadly neutralising antibodies(Bnabs) known as VRC 01 are being studied to see to what extent they can prevent acquisition of HIV-1(efficacy) and to what extend VRC01 can be tolerated by participants (safety). This is a follow up of previous studies which showed that VRC01 is generally safe and well tolerated (HVTN 104). It is a double blind randomized placebo controlled trial. This means that participants do not choose which group they are to be on. The study has 3 groups, high dose VRC01, low dose VRC01 and a placebo group.

They will NOT know which group they are in and the clinicians consulting them will also not know which group the participants are in. Only the site pharmacy personnel are unblended – they know which product is which. This is important to prevent bias. BHP has engaged and continues to engage various stakeholders (including Ministry of Health and wellness, DHMT, clinics) and communities through the BHP community advisory board since 2015 when we were selected to take part in this important study.

The success we are talking about now would not have been possible had the different stakeholders and communities not been on board. What is your role in the Study? I am the study coordinator for the project, responsible for day to day running of the study clinic. The person with overall responsible for the study in Botswana is the site investigator Dr Joseph Makhema. Who are the participants in the study? How many people are required and how many have you enrolled so far? The participants are healthy HIV negative women at risk of acquiring HIV, aged between 18-40 years and willing to take part in the study.

They should not be pregnant or breastfeeding and should be willing to use effective contraception to prevent pregnancy since the effect of VRC01 on pregnancy is unknown. In Sub-Saharan Africa a total of 1900 participants will be enrolled from Botswana, Kenya, Malawi, Mozambique, South Africa, Tanzania and Zimbabwe. 1555 participants have been enrolled as of the end of April. From Botswana a total of 150 participants will be enrolled. In Botswana the AMP study was activated in July, 2016.

The first participant was enrolled on August 16, 2016. To date 236 participants have been screened/checked for eligibility to participate in the study and from these, 122 women have been enrolled and are on study as of May 4, 2018. Willing participants provide written informed consent after discussion of all procedures, and their risks. The informed consent forms, together with the protocol (document that explains how the study is conducted) and other pertinent documents for study conduct are submitted for approval by the Ministry of Health and Wellness, Institutional Review Board(IRB) known as Health Research and Development Committee (HRDC).

This is the committee responsible for approval of research conducted in country. What are the fundamental questions about HIV prevention that the AMP Study is designed to answer? Are people able to “tolerate” the antibody without becoming too uncomfortable? Does the antibody lower people’s chances of getting infected with HIV? If the antibody does lower people’s chances of getting infected with HIV, how much of it is needed to provide protection from HIV? When did it begin and when is it expected to end? In Botswana the study started in July 2016. Total duration of study is 5 years. Each participant stays on study for about two years. What HIV preventive care do volunteers receive and how are you ensuring the safety of study participants? Participants come for study visits monthly.

During these visits, we do what is called “history taking” from the participants to find out how they are feeling and have been feeling. We examine them and we conduct laboratory tests to ensure safety. To prevent HIV infection, we provide risk reduction counselling and HIV prevention package per Botswana Standard of care What impact will this study have in the future of HIV prevention? We generally liken HIV prevention options to a tool box. We currently have various behavioural modification options in this tool box, including abstinence, use of condoms effectively and consistently. It is therefore important to also add more biomedical interventions in this tool box. bNabs would then be an important addition if proven to be effective. This would lead to more combination prevention options.

The idea of a toolbox with more tools in it is important because we know that when people have more choices, it increases the chances that an individual will find one tool that fits their needs and circumstances. Those decisions can be influenced by many factors – cost, ease of use, availability/easy access, partner agrees to use, etc. – so having more tools will mean increasing the chance of serving more people’s needs for HIV prevention. How will the findings benefit Batswana? I would say that it is too soon to say what direct benefit there may be to Batswana. This trial is about proving the concept that bNabs can prevent HIV. More trials will be needed to find the best antibody, or combination of antibodies, how to best administer them as a public health strategy amongst other things.

We know the strides science has made in the war against HIV/AIDS. There are very effective drugs and that is great news. But what do you say to young people that would say to you that it’s no big deal to get HIV and that there are already good drugs to control the disease as if it’s diabetes? Prevention is ALWAYS better than cure. We are truly grateful for the strides that have been made in science to avail great treatments for HIV treatment. We do not yet have all the answers about the various great treatments available, time generally brings things to light.

Additionally, prevention is more cost effective than treatment or a cure. (Note that in the question, diabetes isn’t cured – it is treated as a chronic illness.) That is important to individuals, and to countries/public health systems. From your experience, do you believe that there will be an effective vaccine and/or cure for HIV in our lifetime? Is that an achievable objective you think? Please note that in AMP study, the study agent VRC01 is NOT a vaccine but broadly neutralising antibodies (bNabs).

This study could help us develop a safe and effective HIV vaccine more quickly. An HIV vaccine developed more quickly because of this study could essentially teach the body to make antibodies like VRC01 (without getting the VRC01-like antibody through an IV/drip). To develop a vaccine like that we need to understand more about how VRC01 may work, and how much is needed to “work” (to prevent HIV infection). This study should help us learn that. My answer on vaccine in our lifetime would be YES, The Thai Trial, RV144, showed us a vaccine regimen that could reduce new infections by about 32%. That wasn’t strong enough to license, but it paved the way for a great deal of additional research.

There are 2 efficacy trials currently underway in sub-Saharan Africa testing different vaccine strategies (one of which builds on the Thai results), so we have come farther than ever before. There are various international organizations with scientists whose main focus is the development of the HIV vaccine such as the HVTN, International AIDS Vaccine Initiative(IAVI) etc. I understand that the HIV virus lives not in the blood but lymph nodes and some organs.

Is there any research currently being done to try and flush out HIV from these compartments so that it can be killed by the antiretroviral drugs? To clarify, when a person is on antiretroviral therapy, the amount of virus also known as viral load in blood will reduce. Generally, if a person is not on treatment the viral load will remain high. For people on treatment with low/undetectable viral load, scientists are looking into ways of flushing out HIV from its hiding places like the lymph nodes termed the “shock and kill” strategy.

Currently I am not aware of any such study being conducted in Botswana. HIV was around for decades before it was discovered and diagnosable and infecting humans during that period. Has anything been learnt from that to prevent a recurrence with another type of retrovirus? This is a difficult question, yes human beings are capable of learning to better themselves in the future, to what extent, time will tell. What good news can you give readers of this interview who are living with HIV/AIDS? If someone knows they are living with HIV, it means they have been responsible enough to take the test and know their status. This needs to be commended.

Currently we have available in this country potent antiretroviral treatment with minimal side effects, which means that people living with HIV can have improved quality of life, including sexual reproductive health and live longer. I would also like to take the opportunity to highlight the importance of universal test and treat and for all HIV infected people to be on treatment and to take the treatment diligently. This is important because a persistently undetectable virus is not transmissible.

Continue Reading
Comments

News

VACANCY: President of the UDC

Published

on

Botswana Movement for Democracy (BMD) President, Advocate Sidney Pilane says Umbrella for Democratic Change (UDC) does not have a President.

He revealed this week that UDC leader, Advocate Duma Boko was given the leadership of the coalition on a temporary arrangement. Advocate Pilane who was addressing the media this week, following the expulsion of his party from the UDC stated that in the buildup to 2014 general elections it was agreed that Advocate Boko should be presidential candidate for UDC, an arrangement that ended at the time when the UDC lost the 2014 general elections.

“It was decided that Botswana National Front (BNF) should be given the presidency so that Advocate Boko could be our presidential candidate. The late Gomolemo Motswaledi of BMD was to be his running mate. We made this arrangement in preparation to taking over state power.

So, all that has passed, we contested and lost so it is all in the past,” said the BMD leader. He stated that constitutionally, the UDC has no president because the president has to be elected during the UDC elective congress. Advocate Pilane pointed out that UDC according to the Constitution should hold its congress every three (3) years.

He stated that even all the members of UDC National Executive Committee have to be elected at the congress and as it stands, “there is no president or Vice Presidents because they were not voted into those positions.”

Advocate Pilane said instead of building the UDC brand their colleagues at Botswana Congress Party (BCP) and Botswana National Front have resorted to petty issues. He told the media that the leadership of the two parties have taught their members to insult BMD leadership and its members on social media and any other forum.

He had no kind words for the BCP, calling the party a divisive party that thrives on insults and divisive tendencies. He said the BCP leadership had encouraged its foot soldiers to use social media to insult him and members of the BMD.

According to Advocate Pilane, these are some of the things that have made the two parties remain in opposition for far too long without even coming close to toppling the ruling party. He described them as dishonest people who will plunge the country into chaos and that is why Batswana do not want to give them power.

Continue Reading

News

VIDEO: A Gaborone hotel Prophet caught in the act

Yvonne Mooka

Published

on

In a matter that closely resembles that of a South African Cabinet Minister, Melusi Gigaba’s masturbating video clip, a visiting Zimbabwean Prophet, Ronald El Melchizedek of Altar of Grace this week denied that he has been sending nudes to church sisters and demanding same from them.

In fact, the ‘man of God’ has earned himself the name, ‘Botswana’s Omotoso’ by girls that allege he has sexually exploited them. Pastor Timothy Omotoso is a Nigerian clergyman accused of sexually exploiting over 30 young girls from his church in South Africa.

“He is an Omotoso and even though they hide it at his church, some of us have received messages from him asking for our nudes. Actually, he has asked for my nudes several times,” says one church sister.

The Midweek Sun has gotten hold of a 34 seconds video clip of the youthful prophet playing with his manhood. Looking like he is in a hotel room, the man stands fully naked in a muted video that, depicts him speaking and teasing the recipient. In a standing position, he starts off by caressing his manhood, giving it a close up and ends up lying on the bed, facing up.

At least three young women say they received the video from the prophet and that he usually asks for nudes from them. One of them actually says he has been pestering her, demanding to have sex with her. “He likes to send me messages of how horny he is for me. But again, he likes asking for nudes from women.

Even married women at his church have fallen victims of his sexual harassment. I left the church because he disgusted me by doing such things yet calling himself a man of God,” she says.

The woman however says that Melchizedek, a Zimbabwean who holds services at Gaborone Hotel when he is in the country, is a man of accurate prophecies. “He moves mightily in the prophetic but he likes harassing church sisters. It is known in his church. He is married but controlled by the spirit of lust,” she says.

The Prophet responds
Melchidezek told The Midweek Sun that he was aware of the video of him doing the rounds through WhatsApp, but was quick to label the whole thing a scam.“Yes we are aware. Those are scammers from Benin who hacked into my wife’s Facebook account and phone and stole our videos and pictures. So they wanted to blackmail us and we refused, that is why they are doing that.

It is just an effort to harm the work of God but God is in control,” he told The Midweek Sun. He would not be drawn into responding to, or even discussing the allegations levelled against him by church sisters, but instead gave this reporter a mobile number of a person he said was his wife.

The said woman confirmed that the video was posted by scammers. “That was done by scammers. We have reported them to Benin police,” she said. She however would not give the name of the police station nor go into further details.

This incident follows on last week’s revelations reported by this publication, where several girls spoke anonymously about pastors, prophets and ‘men of God’who were using them sexually in church. Many were uncomfortable to reveal their names, forcing this paper to also conceal the identies of the accused churches and pastors involved in the dirty acts in the name of God.

Continue Reading

Trending